It was great to talk with Professor Xavier Mariette (Université Paris-Saclay and Hôpital Bicêtre, Paris, France) around the current challenges and potential advances in treating Sjögren’s syndrome.
Questions
- Why have so many clinical trials failed in primary Sjögren’s syndrome? (0:15)
- What are the hot topics and latest research you are looking forward to exploring in Sjögren’s syndrome during 2021? (0:39)
Disclosures: Xavier Mariette discloses honorarium from BMS, GSK, Novartis, Pfizer, Servier, UCB and a research grant from Ose Pharmaceutics.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Victoria Jones.
Filmed as a highlight of EULAR 2021 (Virtual).
